• Fri news: Pfizer’s $1B Chinese commitment. RFK Jr. and pharma. Eisai dials back Leqembi forecast. US diabetes burden increase. JNJ gets Varipulse approval. See more on our front page

GSK’s RSV vaccine approved in Canada for adults aged 50 to 59

Quote
cafead

cafead

Administrator
Staff member
  • cafead   Nov 06, 2024 at 08:32: PM
via GlaxoSmithKline (GSK) has received approval for its vaccine, AREXVY, in Canada to prevent lower respiratory tract disease (LRTD) caused by respiratory syncytial virus (RSV) in adults aged 50 to 59 at increased risk for the disease.

article source
 






Top Bottom
Back
Quote